Leadership Overview
Abbott has 10 executives leading key functions including corporate strategy, technology development, information systems, cybersecurity, marketing, and financial operations.
Committed to advancing global health through medical innovation, Abbott delivers life-changing technologies and nutrition products that empower individuals to live healthier lives across every stage of human development.
Committed to advancing global health through medical innovation, Abbott delivers life-changing technologies and nutrition products that empower individuals to live healthier lives across every stage of human development.
Leadership Roles at Abbott
Frederick Sexton - Chief Executive Officer
Frederick Sexton, the Chief Executive Officer at Abbott, directs the overarching strategic vision for the global healthcare enterprise. Overseeing the integration of medical technologies, diagnostics, and nutrition products, the Chief Executive Officer ensures alignment with the mission to improve health outcomes worldwide. This leadership role involves managing complex market dynamics across North America, EMEA, and Asia-Pacific to maintain competitive advantages in chronic disease management. By prioritizing innovation in cardiovascular and diabetes care, Frederick Sexton drives long-term value for shareholders and patients alike. The Chief Executive Officer collaborates with the Board to refine operational priorities, ensuring that the company remains at the forefront of medical science. Through rigorous oversight of global business units, Sexton fosters a culture of excellence that supports the delivery of branded generic medicines and advanced diagnostic solutions to diverse populations, ultimately securing the company's position as a leader in the healthcare industry.
Tabish Aseem - Director, Finance & Chief Financial Officer
Tabish Aseem, the Director, Finance & Chief Financial Officer at Abbott, manages the financial health and fiscal strategy of the organization. Overseeing the budgeting, forecasting, and capital allocation processes, the Director, Finance & Chief Financial Officer ensures that resources are directed toward high-growth areas such as diagnostics and medical devices. This leadership role involves analyzing financial performance to support strategic decision-making at the executive level. By optimizing the cost structure and revenue streams, Tabish Aseem directly impacts the company's ability to invest in long-term innovation. The Director, Finance & Chief Financial Officer coordinates with regional finance teams to ensure fiscal discipline across international operations. Through the implementation of robust financial controls, Aseem supports the delivery of sustainable value to shareholders. This focus on financial integrity ensures that the organization maintains the necessary capital to address critical medical needs and continue its mission of improving health outcomes on a global scale.
Maithilee Mistry - Group Chief Financial Officer (India)
Maithilee Mistry, the Group Chief Financial Officer (India) at Abbott, manages the financial operations and strategic fiscal planning for the Indian market. Overseeing the regional revenue management and cost optimization initiatives, the Group Chief Financial Officer (India) ensures that local business units align with the company's global financial objectives. This leadership role involves navigating complex regulatory environments to support the distribution of diagnostics and nutrition products. By driving financial performance in this key growth region, Maithilee Mistry directly impacts the company's overall international revenue growth. The Group Chief Financial Officer (India) coordinates with local leadership to allocate resources effectively toward addressing regional medical needs. Through the implementation of rigorous financial oversight, Mistry supports the expansion of the company's footprint in emerging markets. This focus on regional fiscal health ensures that the organization remains competitive while delivering high-quality healthcare solutions to a diverse and growing patient population.
Anthony Wild - Chief Technology Officer
Anthony Wild, the Chief Technology Officer at Abbott, architects the digital and technical infrastructure necessary to support advanced medical device development. Overseeing the research and development pipeline, the Chief Technology Officer ensures that engineering teams integrate cutting-edge diagnostics and cardiovascular solutions into the product portfolio. This leadership role involves managing technical partnerships and driving innovation across global manufacturing facilities to enhance production efficiency. By optimizing the technological framework, Anthony Wild directly impacts the speed at which new medical technologies reach the market. The Chief Technology Officer coordinates with cross-functional teams to address complex medical needs, including pain management and chronic disease monitoring. Through the implementation of scalable technical systems, Wild supports the company's commitment to precision medicine. This focus on technological advancement ensures that the organization maintains a robust competitive edge while delivering high-quality, reliable healthcare solutions to patients across international markets.
Rachel Gill - Director, Office of the Chief Information Officer
Rachel Gill, the Director, Office of the Chief Information Officer at Abbott, manages the strategic deployment of information systems across the global enterprise. Overseeing the digital transformation initiatives, the Director, Office of the Chief Information Officer ensures that data architecture supports the company's diagnostic and nutrition business units. This leadership role involves coordinating with IT departments to streamline operational workflows and enhance data security protocols. By optimizing information flow, Rachel Gill directly impacts the efficiency of clinical research and supply chain management. The Director, Office of the Chief Information Officer facilitates communication between technical teams and executive leadership to align digital capabilities with corporate objectives. Through the implementation of robust information management strategies, Gill supports the delivery of innovative healthcare solutions. This focus on digital infrastructure ensures that the organization maintains operational agility while addressing the evolving needs of patients and healthcare providers in diverse geographic regions.
Cory Adams - Cybersecurity & Compliance Chief of Staff
Cory Adams, the Cybersecurity & Compliance Chief of Staff at Abbott, directs the protection of critical digital assets and ensures adherence to global regulatory standards. Overseeing the security posture of medical technology platforms, the Cybersecurity & Compliance Chief of Staff mitigates risks associated with data privacy and system integrity. This leadership role involves coordinating with legal and technical teams to maintain compliance across all diagnostic and pharmaceutical operations. By establishing rigorous security frameworks, Cory Adams directly impacts the safety and reliability of patient-facing digital tools. The Cybersecurity & Compliance Chief of Staff monitors emerging threats to ensure that the company's infrastructure remains resilient against cyber incidents. Through the integration of compliance protocols into product development cycles, Adams supports the delivery of secure, high-quality healthcare solutions. This focus on risk management ensures that the organization upholds the highest standards of data protection while continuing to innovate in the competitive global healthcare landscape.
Lequitha Duff - Chief Marketing Officer I & Production Operator
Lequitha Duff, the Chief Marketing Officer I & Production Operator at Abbott, manages the strategic promotion of nutrition products while overseeing critical manufacturing processes. Overseeing the alignment of marketing campaigns with production output, the Chief Marketing Officer I & Production Operator ensures that market demand for health-focused solutions is met with consistent supply. This leadership role involves analyzing consumer trends to refine the positioning of branded generic medicines and nutritional supplements. By bridging the gap between marketing strategy and operational execution, Lequitha Duff directly impacts the company's market share and revenue growth. The Chief Marketing Officer I & Production Operator coordinates with regional sales teams to optimize product availability across diverse demographics. Through the integration of marketing insights into manufacturing workflows, Duff supports the delivery of high-quality products that address important medical needs. This dual focus on brand visibility and operational efficiency ensures that the organization maintains a strong presence in the global healthcare market.
Christopher Piorkowski - Chief Marketing Officer (Ep) & Divisional Vice President, Medical Affairs, Abbott Ep
Christopher Piorkowski, the Chief Marketing Officer (Ep) & Divisional Vice President, Medical Affairs, Abbott Ep at Abbott, directs the marketing strategy and medical affairs for the electrophysiology division. Overseeing the clinical evidence generation and physician engagement programs, the Chief Marketing Officer (Ep) & Divisional Vice President, Medical Affairs, Abbott Ep ensures that cardiovascular technologies are effectively communicated to healthcare providers. This leadership role involves managing the scientific narrative to support the adoption of innovative cardiac solutions. By aligning medical affairs with marketing initiatives, Christopher Piorkowski directly impacts the clinical success and market penetration of electrophysiology products. The Chief Marketing Officer (Ep) & Divisional Vice President, Medical Affairs, Abbott Ep coordinates with research teams to translate complex clinical data into actionable insights for the medical community. Through the strategic management of professional relationships, Piorkowski supports the company's mission to improve outcomes for patients suffering from cardiovascular conditions across global markets.
Steven Guion - Director, Financial Technical Operations & Chief of Staff
Steven Guion, the Director, Financial Technical Operations & Chief of Staff at Abbott, directs the technical aspects of financial reporting and operational planning. Overseeing the integration of financial systems with business intelligence tools, the Director, Financial Technical Operations & Chief of Staff ensures that data-driven insights inform corporate strategy. This leadership role involves managing the administrative functions of the finance office to improve organizational efficiency. By streamlining financial technical operations, Steven Guion directly impacts the accuracy and speed of corporate financial disclosures. The Director, Financial Technical Operations & Chief of Staff coordinates with cross-functional departments to align operational goals with financial targets. Through the implementation of advanced analytical frameworks, Guion supports the executive team in navigating complex market environments. This focus on technical precision and operational coordination ensures that the organization maintains a strong financial foundation while pursuing its mission to deliver innovative healthcare solutions to patients worldwide.
Mayur Joshi - Chief of Staff, MD's Office
Mayur Joshi, the Chief of Staff, MD's Office at Abbott, directs the operational priorities and strategic initiatives for the Managing Director's office. Overseeing the coordination of executive communications and cross-departmental projects, the Chief of Staff, MD's Office ensures that leadership objectives are executed across the organization. This leadership role involves facilitating collaboration between senior management and functional teams to drive progress on key medical technology projects. By managing the flow of information and strategic planning, Mayur Joshi directly impacts the efficiency of the executive decision-making process. The Chief of Staff, MD's Office coordinates with various business units to ensure alignment with the company's mission of improving health outcomes. Through the implementation of effective project management practices, Joshi supports the delivery of innovative solutions to patients. This focus on operational excellence ensures that the organization maintains a cohesive strategy while addressing the complex challenges of the global healthcare industry.
Explore Leadership Teams in Manufacturing
Fresenius Kabi, a subsidiary of Fresenius, is a global health care company that specializes in medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is headquartered in Bad Homburg, Germany with locations around the world.
Company Leadership MV
SM
CM
RT
Akums, headquartered in Delhi, India, is an international WHO-GMP certified integrated pharmaceutical manufacturing company.
Company Leadership AN
AS
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Company Leadership
CC
BS
SR
At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products around the globe. We strive to innovate further in nuclear diagnostics and therapies so we can enhance the lives of people with cancer.
Every day we see the impact that our treatments offer and the potential they have to provide a world beyond cancer and other debilitating conditions. We continue to push boundaries and reach new heights in everything we do, supported by significant investment into new technologies and therapies.
Company Leadership TG
JP
KE
MF
Frequently Asked Questions Regarding Abbott Top Executives and Leadership Team
